Newsletter

Innovate the way we see life | Tomocube Inc. | February 2026

Mitochondria are no longer background players in cancer biology. They are emerging as active drivers of tumor progression, metabolic adaptation, and therapeutic vulnerability.

Across recent high-impact studies, one pattern is clear: many insights become visible only when mitochondria are observed live, continuously, and without perturbing the system.

This month, we highlight three recent cancer papers that converge on the same message: mitochondrial dynamics matter—and label-free holotomography (HT) plays a critical role in revealing them.

The Emerging Centrality of Mitochondria in Cancer Vulnerability

Across recent high-impact cancer studies, a consistent methodological theme emerges: key biological insights arise not from static snapshots, but from the ability to observe mitochondrial dynamics in living systems over time.

In each case, HT enabled time-lapse visualization of mitochondrial behavior, allowing organelle redistribution and structural adaptation to be captured directly rather than inferred from endpoint measurements.

In a Nature Cancer study, Cangkrama et al. showed that cancer cells physically transfer mitochondria to neighboring fibroblasts, directly reprogramming them into tumor-supportive CAFs. Using HT, mitochondrial transfer events were visualized in real time within live coculture systems, revealing tumor–stroma interaction as a spatially and temporally coordinated process driven by organelle redistribution.

A second study in Cell Reports Medicine extends this idea inward. Vykoukal et al. identified extracellular vesicle–mediated mitochondrial clearance as a survival mechanism in triple-negative breast cancer. Here, HT enabled long-term, time-resolved tracking of mitochondrial-associated structural and mass changes under treatment, capturing adaptive responses that unfold over hours to days—conditions under which fluorescence labeling can introduce perturbation or limit continuity.

These mitochondrial-linked vulnerabilities are not restricted to advanced tumors. In a Gut study, Chen et al. demonstrated that mitochondrial-associated metabolic remodeling already emerges at the precancerous stage in IPMN-associated pancreatic cancer. In this context, HT was used to visualize real-time mitochondrial morphology changes in live cells, validating drug-induced mitochondrial disruption while preserving the integrity of fragile early lesions.

HT imaging of tunneling nanotube (TNT)-like intercellular bridges in MDA-MB-231 cells, revealing elongated, thin connections consistent with structures reported to mediate mitochondrial transfer in cancer–stromal interactions.

From Observation to Quantification

Observing mitochondrial dynamics revealed new mechanisms of cancer progression and vulnerability. The next step is turning these observations into quantitative, reproducible insights.

Holotomography not only enables real-time, label-free imaging, but also supports quantitative analysis of mitochondrial-related phenotypes—including refractive index–based mass distribution and structural remodeling—without compromising cell viability.

To support researchers at this stage, we invite you to explore:

Mitochondria Application Note

TomoAnalysis Pipelines